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Summary The mammary gland is a unique tissue and the defining feature of the genus 10 
mammalia. It is a late-evolving epidermal appendage that has the primary function of providing 11 
nutrition for the young, although recent studies have highlighted additional benefits of milk 12 
including the provision of passive immunity and a microbiome and, in humans, the 13 
psychosocial benefits of breastfeeding. In this review, we outline the various stages of 14 
mammary gland development in the mouse with a particular focus on lineage specification and 15 
the new insights that have been gained by the application of recent technological advances in 16 
imaging in both real-time and three-dimensions (3D), and in single cell RNA sequencing. 17 
These studies have revealed the complexity of subpopulations of cells that contribute to the 18 
mammary stem and progenitor cell hierarchy and we suggest a new terminology to distinguish 19 
these cells. 20 
 21 
Introduction 22 
The mammary gland is a dynamic organ that develops primarily in the adult, undergoing 23 
extensive expansion during puberty, followed by cycles of growth and regression with each 24 
estrus cycle and every pregnancy/lactation/involution cycle. The mammary gland epithelium 25 
is a bi-layer comprised of luminal cells, that line the ductal or alveolar lumen, and myoepithelial 26 
cells (also called basal cells) that surround the luminal layer and contact the stroma comprised 27 
of extracellular matrix, adipocytes and various immune cells. There are three distinct stages of 28 
morphogenesis as depicted in Figure 1. The first commences in utero, around embryonic day 29 
(E) 10.5 in the mouse and 7 weeks in the human fetus (McNally and Stein, 2017; Propper et 30 
al., 2013), and establishes the rudimentary ductal tree that then undergoes isometric growth 31 
postnatally until puberty. A surge in estrogen production at puberty triggers the second 32 
morphogenetic event, which is the formation of club-shaped structures called terminal end buds 33 
(TEBs) at the tips of the ducts. TEBs are comprised of cap and body cells and become sites of 34 
massive proliferation and bifurcation, resulting in a highly branched network of ducts and side 35 
branches that fill the adipose-rich fat pad in which they are embedded. Subsequently, cyclical 36 
expansion and regression of tertiary branches occurs with each estrus cycle. The third, and 37 
most dramatic, morphogenetic event occurs in response to pregnancy with the formation of 38 
lobuloalveolar structures at the tips of tertiary branches, in response primarily to progesterone, 39 
that expand as pregnancy progresses and terminally differentiate during lactation to produce 40 
milk. Concomitant with this expansion of the alveolar epithelium is the de-differentiation of 41 
the adipocytes in the fat pad, most likely to make space for the massive expansion of the 42 
epithelium and provide lipid for milk fat production (Zwick et al., 2018). Notably, when 43 
lactation ceases, these lobuloalveolar structures regress by a combination of programmed cell 44 
 2 
death and tissue re-modelling, and the gland returns to a branched ductal network similar to 1 
the pre-pregnant state. 2 
 3 
There has been considerable interest in identifying and defining mammary stem cells (MaSCs) 4 
and determining their capacity to generate a branched ductal network and lobuloalveolar 5 
structures throughout life. Indeed, since we wrote our first review a decade ago (Watson and 6 
Khaled, 2008), new experimental approaches and technical advances have dramatically added 7 
to our knowledge of mammary gland development. Our view of MaSCs, the utility of the once 8 
gold-standard MaSC transplantation assay (Daniel et al., 1968), and the use of cell surface 9 
markers to isolate and quantify cell subpopulations has changed (Shackleton et al., 2006; Stingl 10 
et al., 2006). It is now clear that there are subsets of MaSCs that may be unipotent or 11 
bi/multipotent, that may be quiescent or proliferative, and that are more or less susceptible to 12 
reprogramming by their microenvironment. The distinction between stem and progenitor cells 13 
is more than semantics and is especially challenging given the plasticity of mammary epithelial 14 
cells. We suggest that new terminology may be useful in describing these different subsets of 15 
stem and progenitor cells (Fig. 2). In brief, we suggest that MaSCs should not be defined by 16 
their expression of cell surface markers nor their ability to repopulate a cleared fat pad, but 17 
should be defined by their true potential in vivo and in situ in the normal mammary gland. In 18 
this context, a MaSC must be at least bipotent with unlimited self-renewal and replicative 19 
potential, while a progenitor cell is lineage-restricted and must be long-lived with high self-20 
renewal and replicative potential. 21 
 22 
In this Review, we provide an overview of the three distinct stages of mammary gland 23 
development, and discuss recent insights into the cell, molecular and genetic events associated 24 
with morphogenetic and functional changes that occur at these stages. The spectacular 25 
expansion of lineage tracing studies in the mammary gland has been prompted by the 26 
generation of lineage-specific promoter-driven reporter genes combined with temporal 27 
induction in defined cohorts of cells, using tamoxifen or doxycycline-inducible constructs 28 
(reviewed in (Zhou et al., 2019)). We highlight recent advances in tissue clearing and deep 29 
imaging, live imaging, single cell RNA sequencing (scRNA-seq) and epigenetic analyses. We 30 
discuss the impact of these new approaches on our understanding of mammary gland 31 
development and the unexpected complexity of the mammary epithelial hierarchy. We draw 32 
on a wide range of studies to provide a comprehensive overview on mammary gland 33 
development, focusing on the mouse mammary gland since this is the most experimentally 34 
tractable species. 35 
 36 
Embryonic mammary gland development 37 
The early stages of mammary gland development are independent of hormones, unlike 38 
subsequent phases. Mammary gland formation is first visualised around embryonic day (E) 39 
10.5 in the mouse by the expression of Wnt10b in bilateral streaks that run from the fore- to 40 
hindlimb buds. These mammary, or milk, lines give rise to five pairs of placodes that are visible 41 
at E11.5, and arise from the surface ectoderm of the embryonic skin. These placodes 42 
subsequently invaginate into the underlying tissue to give rise to buds, which then become 43 
embedded within a condensed mammary mesenchyme. These buds gradually increase in size, 44 
 3 
partly through cell hypertrophy and recruitment of ectodermal cells (Lee et al., 2011) until 1 
E15–E16 when they start to form a primary sprout, which invades the secondary mammary 2 
mesenchyme and branching morphogenesis is initiated (Cowin and Wysolmerski, 2010), and 3 
a nipple sheath is formed (Propper et al., 2013) (Fig. 1A). 4 
 5 
Partly due to their small size and difficulty of detection, investigating the development of 6 
embryonic mammary glands is challenging. Nonetheless, a number of investigative approaches 7 
have been used including reporter gene expression, immunohistochemistry and gene ablation. 8 
Early genetic studies in mice have demonstrated that all five pairs of glands do not require the 9 
same genetic components and although placode pairs develop symmetrically, they do not 10 
develop synchronously: placode 3 appears first, followed by placode 4, then placodes 1 and 5, 11 
and finally placode 2 (Cowin and Wysolmerski, 2010). A striking example of different genetic 12 
regulation is provided by the deletion of Tbx3, which results in loss of the 3rd pair of placodes 13 
(Davenport et al., 2003). In humans, mutations in TBX3 can result in failure to develop breasts, 14 
known as mammary-ulnar syndrome (Jerome-Majewska et al., 2005). The reciprocal signalling 15 
between mammary epithelium and its surrounding stroma is an essential component of 16 
mammary gland morphogenesis. In the embryo, the fibroblast growth factor (Fgf), Wnt, 17 
Ectodysplasin-A1 (Eda) (mediated by NF-kB) and parathyroid hormone related peptide 18 
(PTHrP) signalling pathways are predominant. For example, deficiency in Fgf10 or its receptor 19 
Fgfr2b blocks induction of all mammary placodes except the fourth. In contrast, loss of the 20 
Wnt signal mediator Lef1 leads to absence of only placodes 2 and 3, whereas epithelial 21 
overexpression of the soluble Wnt inhibitor Dkk1 completely prevents mammary placode 22 
formation (Cowin and Wysolmerski, 2010). Although Eda is dispensable for placode 23 
formation, overexpression of Eda in the ectoderm results in the formation of supernumerary 24 
mammary placodes, particularly between placode pairs 3 and 4 (Lindfors et al., 2013). The Eda 25 
pathway regulates expression of Fgf20 that in turn regulates mammary bud growth, and also 26 
TEB formation, ductal outgrowth and branching during puberty (Elo et al., 2017). Other genes 27 
important in determining placode number and formation include Hoxc8, which is transiently 28 
expressed in surface ectoderm at E10.5. Misexpression of Hoxc8 results in the formation of 29 
several ectopic mammary placodes (Carroll and Capecchi, 2015). Formation of placode pairs 30 
3 and 5 requires the repressor function of the Hedgehog signalling pathway regulator Gli3 31 
(Chandramouli et al., 2013a). The initiation of bud outgrowth is triggered by expression of 32 
PTHrP in the epithelium, and mice null for PTHrP or its mesenchymal receptor (PTh1r) display 33 
little to no bud sprouting. The role of the mammary mesenchyme has been further illustrated 34 
using promoter-driven reporter mice for latent TGFβ-binding protein1 (LTBP1), which is 35 
expressed in early mammary mesenchyme at around E12–E12.5 in a halo surrounding each 36 
mammary bud, subsequently becoming restricted to areolar muscle cells (Chandramouli et al., 37 
2013b). LTBP1 is also expressed during the differentiation of the nipple epithelium coincident 38 
with suppression of hair follicle formation in the areola (Chandramouli et al., 2013a). In late 39 
embryogenesis, when the sprout is formed (around E17.5), LTBP1 is expressed in the luminal 40 
cells facing a microlumen. but not in the ductal tips that are multi-layered (Chandramouli et 41 
al., 2013b). This pattern is later reflected in TEBs during puberty, where only cells lining the 42 
lumen express LTBP1 while most body and cap cells do not. 43 
 44 
 4 
Fetal mammary stem cells 1 
It is self-evident that MaSCs are required to generate a functional mammary gland and to 2 
regenerate the gland after periods of regression such as post-lactational involution. Whether 3 
the pools of stem cells are similar or distinct depending on the stage of development has been 4 
a long-standing question. While fetal MaSCs (fMaSCs) must be the source of all other MaSCs, 5 
they may not be required postnatally after the rudimentary branched structure in the fetus has 6 
been formed. Should this be the case, the question arises as to the nature of adult MaSCs; how 7 
they are produced from fMaSCs, and how many subtypes of adult MaSCs exist? Technological 8 
developments in the past decade and the use of lineage tracing studies to complement reporter 9 
gene expression and gene ablation studies have provided exciting new insights into embryonic 10 
mammary gland development and the origin and nature of fMaSCs and their descendants 11 
(Fig. 2). 12 
 13 
One of the first markers of fMaSCs to be identified was Lgr5, a Wnt-regulated target gene. 14 
However, although Lgr5 is a marker for fMaSCs, it is not essential for stem cell activity (Trejo 15 
et al., 2017) and its role is unclear. One study suggests that a single Lgr5-expressing cell can 16 
reconstitute an entire mammary gland, and that Lrg5 is essential for postnatal development 17 
(Plaks et al., 2013), while another suggests that the progeny of Lgr5-expressing cells switch 18 
from a luminal to a myoepithelial fate within the first 12 days of postnatal development (de 19 
Visser et al., 2012). Disruption of another canonical Wnt signaling pathway component Lrp6 20 
results in stunted embryonic branching morphogenesis and an underdeveloped fat pad 21 
(Lindvall et al., 2009). 22 
 23 
FMaSCs arise from keratin 14 (K14)-expressing cells, which first become detectable at E12.5 24 
(although they must arise prior to this stage) and reach peak levels at E18 (Wuidart et al., 2018). 25 
Until recently, fMaSCs were thought to give rise to both luminal and basal lineages (Boras-26 
Granic et al., 2014; Fu et al., 2017; Rodilla et al., 2015; Spike et al., 2012; Trejo et al., 2017). 27 
Although fMaSCs have multipotent activity upon transplantation into a cleared fat pad, their 28 
true developmental potential in situ requires lineage tracing at clonal density. A recent elegant 29 
study using intra-amniotic injection of lentivirus to barcode embryonic epidermal cells at E9.5 30 
(prior to placode formation) has shown that mammary glands are derived from bi-potent 31 
fMaSCs that arise early. Furthermore, a small number of such cells (around 120) are sufficient 32 
to generate an entire mammary gland (Ying and Beronja, 2020). The bipotency of fMaSCs has 33 
been demonstrated further using the multicolour Confetti mouse in combination with 34 
tetracycline-inducible Cre-mediated recombination for clonal analysis (Wuidart et al., 2018). 35 
This study has shown that fMaSCs have a ‘hybrid’ basal and luminal gene expression signature, 36 
and that expression of DNp63 promotes the switch towards a basal cell fate (Wuidart et al., 37 
2018). Another recent study has revealed the complexity of the fMaSC hierarchy (Giraddi et 38 
al., 2018). RNA sequencing of over 1,000 single Epcam+ cells isolated from E18 mammary 39 
glands has shown that individual fMaSCs co-express genes associated with distinct adult 40 
mammary lineages (e.g. luminal and basal) and that fMaSCs can be distinguished from their 41 
precursors and progeny. Interestingly, fMaSCs have heterogeneous transcriptional states and 42 
do not form a distinct subcluster, suggesting that a unique fMaSC population does not exist, at 43 
least at this stage of development (Giraddi et al., 2018) (Fig. 2). It is notable that a single 44 
 5 
embryonic MaSC has a remarkable capacity to contribute to postnatal development, as shown 1 
using a single-cell labelling approach (Lloyd-Lewis et al., 2018a). 2 
 3 
Perhaps the most surprising observation, however, is the early switch from multipotency to 4 
unipotency during embryonic development. This can occur as early as E12.5, as shown using 5 
the Notch1 promoter to drive Cre-mediated recombination of the multicolour Confetti reporter 6 
line followed by imaging whole mount mammary glands in 2-week-old mice (Lilja et al., 7 
2018). Notch1 is expressed in the majority of the cells in the mammary bud (Muzumdar et al., 8 
2007) and cells targeted by the Notch1 promoter in embryogenesis appear to show no lineage 9 
bias. Using a combination of imaging and mathematical modelling, bipotency was revealed to 10 
be undetectable after E15.5 although these cells remain undifferentiated (Lilja et al., 2018). A 11 
role for Notch1 as a master regulator of luminal cell fate has been demonstrated using Notch1 12 
gain of function mice. Ectopic Notch1 activation at the onset of puberty is even sufficient to 13 
switch basal cells to ERα-negative luminal cells (Lilja et al., 2018). This complements the cell-14 
fate switch observed by inducing expression of DNp63 in embryonic or committed luminal 15 
cells (Wuidart et al., 2018), and is consistent with the negative regulation of ΔNp63 by Notch 16 
signalling (Yalcin-Ozuysal et al., 2010). Finally, expression of the zinc finger transcriptional 17 
repressor Blimp1/PRDM1 can be detected in the E17.5 embryonic mammary gland (Elias et 18 
al., 2017). These progenitor cells are long-lived, survive multiple pregnancy/involution cycles 19 
and give rise to progeny that do not express Blimp1, estrogen receptor (ERα) or progesterone 20 
receptor (PR), but are of the Elf5+ lineage (Elias et al., 2017). 21 
 22 
The epigenetic landscape of fetal cells has been recently revealed by single cell ATACseq 23 
coupled with machine learning approaches (Shema et al., 2019). Interestingly, the epigenetic 24 
landscape of E18 fetal cells is partially specified into states that resemble one fetal and three 25 
major adult cell types (basal, luminal progenitor and mature luminal). Thus, these cells are 26 
already poised to differentiate into their corresponding lineages after birth (Chung et al., 2019). 27 
Of note, p63 interacts with KMT2D/MLL4, a major mammalian H3K4 mono- and di-28 
methyltransferase that is essential for enhancer activation during cell differentiation (Lin-Shiao 29 
et al., 2018). Therefore, the Notch1-p63 axis could comprise an epigenetic switch during 30 
mammary lineage determination. 31 
 32 
These experimental approaches could result in rare cell types being missed. Notwithstanding, 33 
the foregoing studies suggest that fMaSCs are a mixed population of true multipotent cells that 34 
arise early, shortly after E9.5, and lineage-primed cells that are not fully committed to either 35 
the basal or luminal lineage before birth. 36 
 37 
Perinatal mammary gland development 38 
Prior to birth, the mammary gland comprises a small ductal tree with one primary duct and 10–39 
15 branches embedded within a nascent fat pad (Boras-Granic et al., 2014). In the perinatal 40 
period, MaSCs become lineage restricted and contribute to either basal or luminal progeny. We 41 
suggest that these long-lived proliferative cells are called basal enduring progenitors (BEP) and 42 
luminal enduring progenitors (LEP) as they are long-lived, unipotent, and have a high 43 
 6 
proliferative and self-renewal capacity. A number of studies have shed light on the timing of 1 
this switch. Labelling of Notch1-expressing cells from post-natal day (P) 3 marks only luminal 2 
cells, while labelling at birth marks only basal cells (Lilja et al., 2018). Interestingly, Notch1 3 
expression is further restricted being found primarily in luminal cells that do not express ERa 4 
by about 3 weeks of age. This conclusion is supported by independent work (Rodilla et al., 5 
2015; Van Keymeulen et al., 2017; Wang et al., 2017). 6 
 7 
A few multipotent, embryonically-derived MaSC do, however, remain. These are mostly 8 
quiescent, retain label for extended periods of time and are long-lived (Boras-Granic et al., 9 
2014; dos Santos et al., 2013). When such cells re-enter the cell cycle, they can contribute to 10 
both luminal and basal lineages (Boras-Granic et al., 2014). The transcriptional regulator 11 
Foxp1 re-activates these cells, at least in part, by repressing the expression of the 12 
transmembrane cell adhesion-associated protein Tetraspanin 8 (Tspan8) (Fu et al., 2018). The 13 
mechanism by which these bipotent cells exit the cell cycle and remain quiescent is unknown; 14 
however, Bcl11b, a zinc finger transcription factor, regulates a subset of quiescent stem cells 15 
by inducing them to enter the G0 phase of the cell cycle (Cai et al., 2017). The functionally 16 
related protein Bcl11a is expressed in mammary placodes from E12.5 and is predominantly 17 
expressed in luminal progenitors in adult mice (Khaled et al., 2015). The rare Bcl11b-18 
expressing cells appear distinct from a small population of proliferative cells marked by 19 
expression of the Wnt3A target gene Procr (protein C receptor) (Wang et al., 2015). 20 
Fluorescence-activated cell sorting (FACS) analysis shows these populations of cells do not 21 
overlap (Cai et al., 2017). Interestingly, Procr-expressing cells are not found in TEBs, and 22 
lineage tracing suggests that only basal and stromal cells express Procr with progeny 23 
contributing subsequently to the luminal lineage. It would be interesting to determine if these 24 
apparently distinct MaSCs serve a different function in the mammary gland, such as 25 
homeostasis versus repair, or if they correspond to different stem cell niches. Thus, with the 26 
exception of long-lived, primarily quiescent, MaSCs, luminal and basal progenitor identities 27 
are imparted at birth and are self-sustaining (Lilja et al., 2018). The molecular signal for this 28 
switch in fate is unlikely to be hormonal given the timing of the switch, unless it is related to 29 
the precipitous drop in progesterone at birth, but it may be epigenetic. 30 
 31 
Pubertal development 32 
Puberty is marked by a rise in the levels of estrogen, inducing the primary ductal network to 33 
rapidly elongate and form an internal lumen (Mailleux et al., 2007). TEBs, club-shaped 34 
structures form at the tips of the elongating ducts and are comprised of an outer single-cell 35 
layer of cap cells and inner multi-layered body cells (Paine and Lewis, 2017) (Fig. 1B). The 36 
cap cells of the TEB express s-SHIP (stem-SH2-containing 5′-inositol phosphatase), a marker 37 
of various tissue stem cell populations (Tu et al., 2001). Expression of a s-SHIP-GFP reporter 38 
becomes undetectable in the subtending duct subsequently becoming reactivated in basal cells 39 
in the alveolar bud during pregnancy (Bai and Rohrschneider, 2010). More recently, these cap 40 
cells express Par3-like polarity protein (Huo and Macara, 2014) and have Wnt/β-catenin 41 
activity that diminishes in concert with s-SHIP in the neck of the TEB. Meanwhile expression 42 
of the alternative Wnt receptor Ror2, which can inhibit β-catenin-dependent signalling, is 43 
upregulated (Roarty et al., 2015). This indicates that Wnt/β-catenin activity, Par3-like protein 44 
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and s-SHIP activity are restricted to basal progenitor cell populations. Most TEB cells are 1 
highly proliferative and contribute to ductal elongation with TEBs bifurcating (or terminating) 2 
stochastically to form branches. TEBs contain lineage-restricted pools of progenitor cells that 3 
exhibit heterogeneous expression profiles (Scheele et al., 2017). Lateral side branching occurs 4 
during the estrous cycle downstream of progesterone signalling that is mediated partly by Wnt4 5 
and RANK (receptor activator of nuclear factor κB) (Tanos and Brisken, 2011) and the 6 
transcription factor Id2 (Seong et al., 2018). Wnts promote survival of the cap cells in TEBs 7 
by preventing the nuclear accumulation of FoxO transcription factors (Chakrabarti et al., 2018). 8 
Wnts are produced by fetal macrophages in response to the secretion of the Notch ligand Delta-9 
like canonical Notch ligand 1 (Dll1) by cap cells. Indeed, it is well established that 10 
macrophages and other leukocytes (Coussens and Pollard, 2011; Gouon-Evans et al., 2000; 11 
Ingman et al., 2006) are required for mammary gland development. Furthermore, analysis of 12 
mammary glands in which the transcription factor signal transducer and activator of 13 
transcription 5 (Stat5) is specifically deleted in macrophages, causes a delay in ductal 14 
elongation while enhancing branching and elevating epithelial proliferation (Brady et al., 15 
2017). Once the mammary fat pad is filled, these TEBs regress and presumably the cap cells 16 
disappear or become quiescent. 17 
 18 
A long-standing question is whether ER- and ER- lineages derive from the same progenitor 19 
(Fig. 2). Using doxycycline-inducible ER-rtTA mice, genetic lineage tracing of ER+ luminal 20 
cells has been performed (Van Keymeulen et al., 2017). These studies conclude that ER+ cells 21 
are derived from ER+ lineage-restricted progenitors, which maintain this lineage during adult 22 
life (Van Keymeulen et al., 2017). Other work tracing cells that express Prominin-1 23 
(PROM1/CD133) reveals that these cells contribute to only the ER+ lineage, while in contrast 24 
SOX9-expressing cells maintain the ER- lineage (Wang et al., 2017). However, ablation of 25 
Prominin-1 has shown that it is not essential for mammary gland function, although in its 26 
absence there is reduced ductal branching (Anderson et al., 2011). Prominin-1 is unlikely to be 27 
a driver of the ER+ lineage. 28 
 29 
Although studies using lineage-specific promoters have provided valuable insights into the 30 
mammary epithelial cell hierarchy (Asselin-Labat et al., 2010; Rios et al., 2014; Van 31 
Keymeulen et al., 2011), there are caveats associated with this biased approach. First, these 32 
studies have utilised different mouse strains, some with, for example, human or bovine 33 
promoters and others with the Cre recombinase or tetracycline responsive elements knocked-34 
in to the 3′UTR of the endogenous gene. This could result in different patterns of expression 35 
and the treatment of animals with tamoxifen or tetracycline could itself perturb the growth of 36 
mammary epithelial cells differentially. Secondly, a minimal level of expression may be 37 
required to express sufficient Cre recombinase to mediate recombination at the reporter locus 38 
and so a subset of cells may be missed. In addition, recent reports of endogenous ER 39 
transcription without translation could impact the interpretation of lineage tracing data (Cagnet 40 
et al., 2018). Furthermore, two subpopulations of luminal ductal cells, expressing either high 41 
or low levels of keratin 8 (K8), have been detected, using tissue clearing and deep 3D imaging; 42 
surprisingly, only a single K8+ cell is present in each alveolus at lactation (Davis et al., 2016). 43 
Thus, the use of the K8 promoter to drive a reporter gene could potentially generate misleading 44 
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data. A completely agnostic approach would overcome the confounding issues of utilising 1 
specific promoters and mis-interpreting cellular proximity (Box 1). 2 
  3 
The pregnancy/lactation/involution cycle 4 
Pregnancy 5 
During pregnancy, tertiary branching and the formation of lobuloalveolar structures at the duct 6 
tips occurs in response to rising levels of progesterone and prolactin (Fig. 1C). This process, 7 
called alveologenesis, requires massive proliferation that is mediated by a number of signals 8 
including Stat5 (Cui et al., 2004), Elf5 (Oakes et al., 2008), Stat6 (Khaled et al., 2007) and 9 
RANKL (Fata et al., 2000). The two types of luminal cells that constitute growing lobuloalveoli 10 
during pregnancy are either hormone sensing ER+/PR+ cells (which usuall_ co-express Gata3), 11 
or hormone responsive (ER/PR negative) pStat5/Elf5+ cells (Oliver et al., 2012) (Fig. 2). 12 
Conditional ablation of ERa in the mammary epithelium demonstrated its essential role for 13 
ductal and alveolar morphogenesis (Feng et al., 2007), while PR is required during pregnancy 14 
for mammary ductal side-branching and alveologenesis (Brisken et al., 1998; Lydon et al., 15 
1995). Recently, it has been shown that rare progenitor cells expressing the zinc finger 16 
transcriptional repressor Blimp1, give rise to proliferative pStat5/Elf5+ cells during pregnancy 17 
and are a long-lived population that survive involution (Ahmed et al., 2016; Elias et al., 2017). 18 
These data further support the presence of two different lineages of alveolar cells during 19 
pregnancy. 20 
 21 
Early studies have shown that the prolactin receptor activates Stat5a signalling and is essential 22 
for alveologenesis (Cui et al., 2004; Liu et al., 1997; Oakes et al., 2008) while Stat5b mediates 23 
growth hormone signalling. However, more recent work has demonstrated that both Stat5a and 24 
Stat5b are important for regulating the expression of mammary-specific genes during 25 
pregnancy and lactation (Yamaji et al., 2013). Alveolar differentiation progresses throughout 26 
pregnancy, with a number of genes activated early while others are expressed just before birth. 27 
Stat5 regulates the expression of a large set of approximately 750 of these genes that display 28 
chronological activation (Yamaji et al., 2013). Milk protein genes, such as whey acidic protein 29 
(Wap) and b-casein (Csn2), are induced more than 1,000-fold during pregnancy. This reflects 30 
the presence of mammary-specific super-enhancers (transcription factor sites highly enriched 31 
for active chromatin marks). Indeed, analysis of the Wap super-enhancer suggests a temporal 32 
and functional enhancer hierarchy (Shin et al., 2016). Gene promoters bound by Stat5 have 33 
H3K4me3 (trimethylated histone H3 at K4) marks at the onset of lactation.  34 
 35 
There is an extensive literature on the other factors that control mammary gland development 36 
during pregnancy (Oakes et al., 2006). Recent seminal studies have revealed a more complex 37 
picture of cell subsets using lineage tracing of alveolar progenitors and scRNA-seq. 38 
Furthermore, it has been shown that there is an ‘epigenetic memory’ of pregnancy, which may 39 
shed light on the protective effect of an early pregnancy (Dos Santos et al., 2015; Meier-Abt 40 
and Bentires-Alj, 2014) (Box 2). 41 
 42 
Lineage tracing of alveolar progenitors 43 
 9 
As we have discussed, a number of studies have employed lineage tracing to characterise the 1 
progeny of MaSCs and progenitor cells, and their contribution to mammary gland development 2 
at embryonic, perinatal and pubertal stages (reviewed in (Fu et al., 2020; Lloyd-Lewis et al., 3 
2017; Sale and Pavelic, 2015)). Moreover, labelling at saturation density using the 4 
doxycycline-inducible systems has allowed the fate of all luminal or basal cells to be followed 5 
throughout pregnancy and lactation (Wuidart et al., 2016), concluding that luminal and basal 6 
lineage progenitors are unipotent even following pregnancy, lactation and remodelling of the 7 
gland. 8 
 9 
The ability of a single stem/progenitor cell to contribute to lobuloalveolar structures has also 10 
been analysed in lactating mice using the R26[CA]30EYFP ‘slippage’ mouse model (Davis et al., 11 
2016) and Box 1. A surprising variety of clonal patterns was observed, with some alveoli being 12 
almost completely labelled whilst others had intermediate levels and some had no labelled 13 
progeny at all (Davis et al., 2016). The labelled clones were either basal or luminal, but never 14 
both, and clonal regions spanned up to 100 alveoli. These observations could be interpreted to 15 
suggest that an alveolar progenitor cell niche is located at the base of a secondary branch. 16 
Whether this niche contains both LEPs and BEPs is difficult to determine. It is clear that there 17 
is a huge expansion of luminal alveolar cells during pregnancy but whether this applies to basal 18 
cells is less clear. Given the sparse covering of alveolar clusters with basal cells, compared to 19 
the tightly packed parallel lines of myoepithelial cells in ducts (Hitchcock et al., 2020), it is 20 
possible that proliferation of the basal cells is not required and they simply stretch out over 21 
expanding luminal alveolar cells. In this context, an interesting observation for one particular 22 
clone of cells labelled in the R26[CA]30EYFP mouse model, was the presence of a single EYFP-23 
labelled cell in each alveolus within a lobuloalveolar cluster indicating a sub-lineage that 24 
comprises a minor component of each alveolus. The nature and role of this cell type is open to 25 
speculation, but it is worth noting that only approximately one cell per alveolus shows 26 
immunostaining for K8 compared to a high proportion of the luminal ductal cells. It is not 27 
apparent why these data do not support a previous study indicating that alveoli can be derived 28 
from the progeny of a single cell (van Amerongen et al., 2012), but may be a consequence of 29 
analysing progeny of clones that coincide due to labelling at non-clonal density. These results 30 
highlight the power, and the importance, of in vivo lineage tracing at clonal density. 31 
 32 
Transcriptome analyses to identify progenitor populations 33 
Several studies have analysed the transcriptome of individual mammary epithelial cells at 34 
different stages of development, and with different conclusions. Bach and colleagues used 35 
scRNA-seq to examine four developmental stages (nulliparous, mid gestation, lactation and 36 
post involution) to reveal 15 clusters based on gene expression. However, none of the clusters 37 
could be defined by the expression of a single gene, which is an important consideration when 38 
interpreting and performing lineage tracing studies (Bach et al., 2017). In contrast to the recent 39 
lineage tracing studies discussed above, pseudotime trajectory analysis suggests that there is a 40 
common luminal progenitor that can give rise to intermediate, restricted alveolar and hormone-41 
sensing progenitors that subsequently undergo changes in their transcriptome in response to 42 
the pregnancy cycle (Bach et al., 2017). A similar finding has been reported by Giraddi and 43 
colleagues – also using scRNA-seq (Giraddi et al., 2018) – and further supported by their 44 
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follow up study of chromatin using scATAC-seq (Chung et al., 2019). It is possible that these 1 
bipotent luminal cells are mostly active during early embryonic and prepubertal stages. 2 
However, the analysis and interpretation of single cell genomics data is still in its infancy and 3 
this may explain why another study (Pal et al., 2017) reached different conclusions. Pal and 4 
colleagues suggest that gene expression in the pre-pubertal epithelium shifts from a basal-like, 5 
fairly homogeneous programme, to clear-cut lineage-restricted programs in puberty (Pal et al., 6 
2017). Furthermore, their data uncovered an apparent mixed-lineage cluster within the basal 7 
clusters that is not observed in the other two studies (Bach et al., 2017; Giraddi et al., 2018). 8 
Whether the cells in this cluster are quiescent fMaSCs is an open question. Importantly, 9 
scRNA-seq studies have revealed many cellular intermediates, particularly in the luminal 10 
compartment, that could be transit amplifying lineage-committed cells. These results also point 11 
towards the potential plasticity of this compartment, something worth noting when considering 12 
the growing evidence that most breast cancers originate from luminal cells. 13 
 14 
Lactation 15 
During late gestation, milk secretion is regulated by high levels of progesterone so, although 16 
milk and fat droplets are produced, these are usually not secreted and can be observed within 17 
the luminal epithelial cells. However, upon the precipitous drop in progesterone that occurs at 18 
birth, a final round of proliferation takes place and the fat pad becomes filled with ductal and 19 
alveolar epithelium (Fig. 3). This is associated with a loss of differentiated adipocytes. There 20 
is some evidence of reciprocal transdifferentiation of adipocytes and epithelium (Morroni et 21 
al., 2004; Prokesch et al., 2014), but this is controversial; more recent evidence does little to 22 
resolve this issue with one study suggesting that this does not occur (Zwick et al., 2018) while 23 
another shows that only adipocyte progenitors can become epithelial (Joshi et al., 2019). These 24 
conflicting views may be the result of different experimental approaches. In this context it is 25 
interesting that stromal cells express Procr so could it be that these stromal cells contribute to 26 
the luminal lineage rather than bipotent Procr-expressing MaSCs? In the light of a study 27 
showing that breast cancer cells, which are undergoing epithelial mesenchymal transition 28 
(EMT), can be induced by drug treatment to differentiate into adipocytes thereby reducing 29 
metastasis (Ishay-Ronen et al., 2019), this transdifferentiation potential becomes an important 30 
question to resolve. In this next section, we discuss the key features of lactation, such as the 31 
requirement for polyploid cells, the mechanism of milk secretion and important interactions 32 
with stromal components. 33 
 34 
Polyploidy 35 
Lactation is a time of high demand for energy and protein production. Indeed, the synthesis of 36 
milk proteins dramatically increases the total amount of protein produced by secretory alveolar 37 
cells. One mechanism for achieving this elevated protein production would be to enhance the 38 
translational machinery of the cell. Gilbert and Vonderhaar suggested almost four decades ago 39 
that the full differentiation of secretory alveolar cells ‘requires DNA synthesis inconsequent of 40 
mitosis’ and that this could involve polyploidy (Smith and Vonderhaar, 1981). Recent studies 41 
highlighting the presence of binucleate cells in the lactating mammary glands of mice, cows, 42 
marsupials and humans have confirmed this theory (Ho et al., 2016; Rios et al., 2016). Genetic 43 
confirmation of the requirement for binucleate cells for functional differentiation of the mouse 44 
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mammary gland is provided by Aurora kinase A conditional knockout mice (Rios et al., 2016). 1 
Aurora kinase A is a mitotic spindle-associated kinase, required for spindle formation and the 2 
progression of mitosis. Interestingly, while basal cells deficient in Aurora A are unaffected, the 3 
number of binucleate luminal cells is drastically reduced and this has a striking effect on the 4 
growth of pups suckled by Aurora A deficient dams, which fail to thrive after 4 days of 5 
suckling. The number of binucleate cells can also be perturbed by ablation of the KRAB-6 
domain zing finger protein Zfp157 (also known as Roma), a transcriptional target of Stat6 7 
(Oliver et al., 2012). In the absence of Zfp157, luminal cells continue to undergo DNA 8 
replication but fail to divide resulting in an elevation of the number of binucleate cells that is 9 
accompanied by evidence of considerable DNA damage (Ho et al., 2016). It is intriguing that 10 
cells harbouring such damaged DNA do not die but continue to produce milk. In this context, 11 
note that knockout of Zfp157 compensates for the loss of Gata3 and rescues lactation failure 12 
that arises when Gata3 is deleted (Oliver et al., 2012). Thus, Gata3 is not essential for 13 
development during pregnancy so long as Zfp157 is absent, although cells appeared dysplastic 14 
during lactation. 15 
 16 
Milk secretion 17 
Lactation requires the contraction of the myoepithelial network in response to oxytocin. The 18 
development of new live imaging techniques has shed light on this dynamic process. Using 19 
live 3D imaging, it has been shown that Orai1, which is a store-operated Ca2+ channel subunit, 20 
is required for the frequency and coordination of the oxytocin-mediated pulsatile contractions 21 
that expel milk into ducts (Davis et al., 2015). More recently, the ultrasensitive protein calcium 22 
(Ca2+) sensor GCaMP6f has been used in transgenic mice to show that Ca2+ increases in single 23 
basal cells in response to oxytocin, immediately before their contraction, suggesting that basal 24 
cells contract – and thus deform – luminal cells to eject milk. A different approach has focussed 25 
on observing lipid droplet fusion and secretion, using intravital imaging of the lactating 26 
mammary gland in live transgenic mice expressing green fluorescent protein (GFP). Lipid 27 
droplets were stained with the hydrophobic fluorescent dye BODIPY (boron-dipyrromethene) 28 
and their formation and secretion monitored by time-lapse subcellular microscopy over the 29 
space of 1-2 hours. Notably, oxytocin-induced contraction of the myoepithelial cells is required 30 
to release the droplets into the alveolar lumen (Masedunskas et al., 2017; Mather et al., 2019). 31 
 32 
Epithelial–basement membrane and cell adhesion interactions 33 
Interaction of mammary epithelia cells with the basement membrane is essential for proper 34 
differentiation of alveolar cells and the maintenance of lactation. The laminin binding integrin 35 
chains α3 and α6 are required for lobuloalveolar development at the appropriate time and are 36 
essential to maintain lactation, because conditional deletion of these integrins causes 37 
precocious involution (Romagnoli et al., 2020). Although these studies have relied on 38 
transplantation and mammosphere assays, it is possible that integrins are involved in 39 
maintaining the MaSC or progenitor cell niche (Romagnoli et al., 2019). An interesting adjunct 40 
to this study is the demonstration that a6 integrin is inherited asymmetrically by orientating at 41 
one spindle pole when daughter cells divide (Morris et al., 2020). Also, the tight junction 42 
protein, Occludin, has been shown to have an unanticipated role as modulator of endoplasmic 43 
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reticulum (ER) stress, that is a feature of late lactation, by facilitating protein secretion in a 1 
SNARE-dependent manner (Zhou et al., 2020). 2 
 3 
Myoepithelial–immune cell interactions 4 
Recent studies using tissue clearing and deep imaging of lactating mammary glands have 5 
revealed the unexpected interaction between leukocytes and myoepithelial cells, which adopt 6 
the same stellate shape and are intimately associated with each other (Dawson et al., 2020; 7 
Hitchcock et al., 2020). This phenomenon has also been observed using fluorescent tracking 8 
of macrophages (Stewart et al., 2019), suggesting that leukocytes may carry out surveillance 9 
of luminal space in order to detect pathogens. This notion is supported by the serendipitous 10 
discovery of a gene that regulates lactation which arose from an ENU-mutagenesis screen that 11 
identified a mutation in the viral sensor Oas2 as a cause of lactation failure in the immediate 12 
post-partum period (Oakes et al., 2017). It is not unexpected that a viral recognition pathway 13 
would have a role in the regulation of lactation, because it is well established that viruses can 14 
be transmitted in milk. The robust activation of an interferon response in Oas2 mutant 15 
mammary glands suggests that viral detection could trigger cessation of milk production. Thus, 16 
the mammary gland may balance maximum milk production with an assessment of milk quality 17 
in terms of pathogenic organisms. It is now clear that organisms in the milk make an essential 18 
contribution to the microbiome of the infant gut. 19 
 20 
Involution 21 
After lactation ceases, the alveolar compartment regresses and the mammary gland is 22 
remodelled to an arbourised ductal tree that resembles a virgin gland, albeit with more side-23 
branches. The process of involution is characterised by extensive programmed cell death and 24 
has been utilised as one of the most dramatic models of physiological cell death. In vivo, 25 
involution is a gradual process but in an experimental setting involution can be synchronised 26 
by either removal of the suckling pups at the peak of lactation (day 10 in the mouse) or by the 27 
sealing of teats with veterinary glue (Watson, 2006b). The latter approach allows for the 28 
investigation of locally-acting factors with the contralateral glands serving as controls (Li et 29 
al., 1997). Involution is triggered by the accumulation of milk and occurs in two distinct phases: 30 
first, a reversible phase that is marked by rapid and extensive cell death with limited alveolar 31 
collapse, and a second, irreversible phase that is accompanied by tissue remodelling and the 32 
reappearance of adipocytes (Lund et al., 1996; Watson, 2006b). The first phase lasts for up to 33 
48 hours in the mouse and lactation can recommence if the pups are returned to the dam. In 34 
other species, the length of the first phase is more difficult to determine, but it is suggested to 35 
be 11 days in the cow and up to 3 weeks in the fur seal (Sharp et al., 2007). A caveat with 36 
forced involution is that it does not occur naturally, unless the pups die, and there is some 37 
evidence of differences post forced involution including higher levels of inflammation and 38 
ductal hyperplasia (Basree et al., 2019). Nevertheless, forced involution does occur in women 39 
who chose not to breastfeed or who force wean their child either for health reasons or upon 40 
returning to work.  41 
 42 
Programmed cell death during involution 43 
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It has long been thought that cells die during involution by the process of apoptosis (Watson, 1 
2006a), a mechanism of programmed cell death that utilises caspase proteases to dismantle the 2 
dying cell (Inoue et al., 2009). However, more recent studies have highlighted that this is not 3 
the case and that the first phase of involution is independent of executioner caspase activity. 4 
Instead, the luminal alveolar cells die via a lysosomal-mediated pathway of cell death 5 
(Kreuzaler et al., 2011; Sargeant et al., 2014). Historical electron microscopy studies had 6 
suggested that there are changes in the lysosomal compartment during involution and that the 7 
lysosomal hydrolase cathepsin D is released from lysosomes (Helminen and Ericsson, 1970; 8 
Helminen and Ericsson, 1971; Helminen et al., 1968), and more recently, cathepsin D is 9 
processed and active during involution (Margaryan et al., 2010; Zaragozá et al., 2009). 10 
 11 
Confirmation of a role for the lysosomal compartment in mediating cell death during involution 12 
followed on from the discovery that the transcription factor Stat3 is required for the initiation 13 
of involution (Chapman et al., 2000) Microarray analysis of Stat3 target genes revealed a 14 
dramatic 60-fold upregulation of serpina3G (known as Spi2a) mRNA in mammary glands of 15 
24 hour involution Stat3 conditional knockout mice. Spi2a is an irreversible inhibitor of 16 
cathepsin proteases and prompted the discovery that the expression of cathepsins B and L is 17 
dramatically upregulated in early involution, in a Stat3-dependent manner, concomitantly with 18 
the Stat3-mediated inhibition of Spi2a expression (Kreuzaler et al., 2011). Subsequent studies 19 
have shown that the uptake of lumenal milk fat globules (MFGs) is enhanced by Stat3 (Sargeant 20 
et al., 2014), which modulates also trafficking of proteins, such as annexins and flotillins, from 21 
the plasma membrane to the lysosome (Lloyd-Lewis et al., 2018). Thus, involution is a 22 
dynamically regulated process that is orchestrated by Stat3, which enhances the lysosomal 23 
compartment and switches the fate of luminal cells from their secretory function to a 24 
phagocytic function resulting in the delivery of MFGs to lysosomes. Degradation of the lipid 25 
in the MFGs to constituent fatty acids results in elevation of the levels of oleic acid that is 26 
proposed to perturb the lysosomal membrane, allowing the release of cathepsins to kill the cell 27 
(Fig. 4). The fate of the alveolar myoepithelial cells is less clear; recent deep imaging studies 28 
suggest that they may not die, but contract and shrink back to the ductal tree (Hitchcock et al., 29 
2020). If this supposition is correct, then the network of myoepithelial cells that surrounds each 30 
alveolus may arise from ductal myoepithelial cells that adopt a different shape when in contact 31 
with alveolar epithelium. 32 
 33 
The zinc transporter ZnT2 has also been suggested to play a role in lysosome biogenesis and 34 
lysosome-mediated cell death during involution (Rivera et al., 2018), confirmed using ZnT2 35 
knockout mice that exhibit impaired alveolar regression, together with reduced levels of pStat3. 36 
Furthermore, vacuolar ATPase assembly on lysosomes is inhibited resulting in fewer, smaller, 37 
lysosomes. Thus, ZnT2 is an important regulator, along with Stat3, of elevated lysosome 38 
biogenesis at the onset of involution (Rivera et al., 2018). 39 
 40 
As milk production halts, calcium transport into milk ceases. The calcium pump ATPase 2 41 
(PMCA2), which is located at the apical surface of the plasma membrane, transports calcium 42 
into milk and interacts with the PDZ domain-containing scaffolding molecule sodium-43 
hydrogen exchanger regulatory factor (NHERF1), which is upregulated during lactation (Jeong 44 
 14 
et al., 2019). Importantly, genetic ablation of NHERF1 revealed that it is required to suppress 1 
Stat3 activation during lactation and thereby prevents premature involution. At the onset of 2 
involution, expression of both PMCA2 and NHERF1 is downregulated leading to lysosome-3 
mediated cell death via Stat3 activation. The increase in cytosolic Ca2+ levels in luminal 4 
epithelial cells during involution is likely to activate calpains, Ca2+-sensitive non-lysosomal 5 
cysteine proteases (Arnandis et al., 2012).  6 
 7 
Adipocyte regeneration 8 
During involution, the white adipocyte compartment extensively regenerates filling space 9 
occupied by the regressing luminal epithelium. The mechanism regulating adipocyte 10 
regeneration is largely unknown, but recent studies using genetic tracing of mature adipocytes 11 
have revealed that hypertrophy is the primary mechanism (Zwick et al., 2018), with no 12 
evidence for transdifferentiation of luminal epithelial cells to adipocytes during involution. 13 
Interestingly, these adipocytes fill with lipids derived from milk and in the absence of lipid 14 
trafficking to adipocytes, the mammary epithelium fails to properly remodel. 15 
 16 
Remodelling and immune cells 17 
Since the mammary gland can generate full lactational competence with every pregnancy, this 18 
indicates that the remodelling process during involution occurs without inflammation or tissue 19 
damage. This may be due in part to the influx of immune cells during involution that clear milk 20 
and debris (efferocytosis)(Martinson et al., 2015; O'Brien et al., 2010; O'Brien et al., 2012). 21 
Mammary epithelial cells themselves act as non-professional phagocytes and re-uptake milk 22 
fat droplets and dead cells (Sargeant et al., 2014). The receptor tyrosine kinase MerTK is 23 
elevated early in involution and loss of MerTK results in accumulation of dead/dying cells in 24 
post-lactational MerTK-deficient mammary glands, but this is not observed when the other 25 
family member receptor tyrosine kinases Axl and Tyro3 are deficient (Sandahl et al., 2010). 26 
Thus, efferocytosis mediated by MerTK is essential for controlled involution, and may help to 27 
prevent accumulated dead cells rupturing and releasing intracellular components that could 28 
damage the surrounding ducts. It has been suggested that milk engorgement can cause tissue 29 
damage, and that the molecules released are recognised by Toll-like receptor 4 (TLR4), which 30 
triggers an inflammatory response and milk stasis (Glynn et al., 2014; Ingman et al., 2014). 31 
 32 
As discussed, studies using tissue clearing and deep imaging of lactating mammary glands have 33 
revealed the unexpected interaction between leukocytes and myoepithelial cells (Hitchcock et 34 
al., 2020). In early involution, the shape and association with myoepithelial cells is maintained 35 
but by as involution progresses, the number of leukocytes increases substantially and they 36 
begin to adopt a different shape at 72 hours of involution (Hitchcock et al., 2020). 37 
Immunofluorescence studies show that the majority of these leukocytes express activated MHC 38 
class II antigens and are, therefore, likely to be macrophages or dendritic cells. These images 39 
confirm previous studies showing an influx of macrophages during involution which are 40 
required for the involution process (O'Brien et al., 2010; O'Brien et al., 2012). The study of 41 
involution has provided insights into possible mechanisms of breast tumorigenesis. 42 
Furthermore, involution can be viewed as tumorigenesis in reverse since epithelial cells are 43 
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induced to die, concomitantly with remodelling and reduction of associated vasculature and 1 
lymphatics (Elder et al., 2018). 2 
 3 
Technical challenges and outstanding questions 4 
The past decade has seen unprecedented progress in understanding mouse mammary gland 5 
development. Much of this is a consequence of technological developments, such as high 6 
throughput sequencing and advanced microscopy. It might also be said that much of the work 7 
in the past decade has utilised approaches, such as FACS and fat pad transplantation, which 8 
resulted in conclusions about MaSC markers and MaSC characteristics that do not necessarily 9 
reflect their capacity in situ and in vivo. The continued emergence of new technologies to 10 
analyse the mammary gland provides not just impetus to the field, but results in a continuous 11 
state of revelation and subsequent refinement of our ideas and understanding. As a community, 12 
however, we need to be critical of the shortfalls and caveats associated with these advances. 13 
For example, single cell genomics is quickly becoming a staple for the analysis of tissue 14 
heterogeneity and cell fate decisions. However, unlike lineage tracing, single cell genomics 15 
reports on the current epigenetic or transcriptomic state of a cell and not on its history or 16 
potential. Also, lineage trajectories based solely on single cell genomics are computationally 17 
derived and embrace the nascent field of computational biology that is constantly evolving. 18 
Promoter-driven lineage tracing has undoubtedly contributed to major paradigm shifts in our 19 
understanding of mammary gland biology over the last 10 years. However, there are caveats to 20 
this technology, such as the use of reporter knock-ins that disrupt one allele of the gene of 21 
interest (e.g. Gata-3 is haploinsufficient)(Lawrence et al., 2016), untargeted transgenes that use 22 
minimal promoter sequences from different species as surrogates for in vivo gene expression 23 
patterns, and the use of BAC transgene reporters. These different transgenic approaches could 24 
lead to different conclusions being drawn. Interpretation is further confounded by evidence that 25 
transcription does not necessarily equate with protein production and/or stability. Finally, due 26 
account needs to be taken of the influence of the different genetic backgrounds used in 27 
generating these models. As a community, we need to assess these many variables that impact 28 
upon the interpretation and conclusions of new findings. A concerted effort to provide multi-29 
lab benchmarking studies to determine the impact of technical differences, tools and mouse 30 
strains on the interpretation of new results would be a valuable resource.  31 
 32 
One outstanding question is the nature and location of the mammary stem and progenitor cells 33 
and their niches, and how they reciprocally interact with, and shape, nonepithelial cells within 34 
their microenvironment. Cells are constantly exposed to varying levels of hormones and cycles 35 
of growth and regression. Maintaining stem/progenitor cells within a niche is essential to 36 
ensure their long-term survival and potency. It is also important to understand how, during 37 
early stages of tumour initiation, tumour initiating cells dictate tumour promoting changes in 38 
the microenvironment and how that is related to the normal biological functions of the cell of 39 
origin. The emergence of spatial transcriptomics will play a major role in understanding these 40 
questions and one could foresee this being coupled with unbiased lineage tracing for high 41 
resolution mapping of stem/progenitor niches. 42 
 43 
 16 
The nature of mammary stem cells and their niche was first suggested by the late Gil Smith 1 
over 30 years ago in his seminal electron microscopy study (Smith and Medina, 1988). Gil’s 2 
hypotheses were so often subsequently shown to be correct, including the notion that a single 3 
stem cell could generate an entire mammary gland (Kordon and Smith, 1998). We have made 4 
enormous progress in the 50 years since mammary gland stem cells were first shown to exist 5 
through fat pad transplantation assays (Daniel et al., 1968; Hoshino and Gardner, 1967) but the 6 
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Box 1. Unbiased approaches to lineage tracing. 41 
One such approach allows the progeny of a single cell to be traced using a slippage cassette,  42 
encompassing a [CA]30 microsatellite repeat directly upstream of an out-of-frame reporter gene 43 
inserted into the Rosa26 locus (Kozar et al., 2013).. A DNA replication error could put the 44 
reporter into frame and since such replication errors are extremely rare, and occur stochastically 45 
in any cell type, there is no bias in the labelling of any single cell whose progeny can be traced 46 
at clonal density. This model has been combined with tissue clearing and deep 3D imaging 47 
procedures in mammary gland where only 1-2 labelling events were detected on average per 48 
gland thus eliminating any possibility of clone convergence. This approach demonstrated that 49 
 26 
the progeny of a highly proliferative labelled progenitor are unipotent in the adult with only 1 
luminal or basal clones being detected (Davis et al., 2016). Labelled progeny are distributed 2 
sporadically to branching ducts and quantification of their contribution to entire ductal trees 3 
suggested that pools of around 20 LEPs and 15 BEPs are sufficient to generate a major duct 4 
during puberty (Davis et al., 2016). These numbers are not dissimilar from the estimates 5 
achieved by lentiviral barcoding around E9.5 discussed in the main text (Ying and Beronja, 6 
2020). The integration of unbiased lineage tracing, using other technologies such as CRISPR-7 
Cas9-induced genetic scars, coupled with single cell genomics such as scGASTALT (Raj et 8 
al., 2018; Spanjaard et al., 2018), is an exciting new area that will resolve many of the questions 9 
around cell fate decisions in the mammary gland. 10 
 11 
Box 2. Epigenetic control in pregnancy 12 
Interestingly, ductal branching is initiated faster in parous than non-parous mice (Dos Santos 13 
et al., 2015). Analysis of the epigenome shows that this is associated with considerable and 14 
long-lasting reductions in DNA methylation, primarily at sites occupied by Stat5a during 15 
pregnancy. Thus, epigenetic memory of pregnancy may facilitate subsequent differentiation 16 
cycles, which might partly explain why women produce milk faster in second and subsequent 17 
lactations. These epigenetic changes may also partly explain the protective effect of 18 
pregnancies lasting 34 weeks or longer for breast cancer development (Husby et al., 2018), 19 
although the biological mechanism behind this is a key question. One candidate is the IGF1 20 
receptor pathway, because the Igf1r gene is hypermethylated in the parous mouse mammary 21 
gland (Katz et al., 2015). RNA-Seq data demonstrates that cells in the post-parous luminal 22 
compartment have different transcriptional profiles than comparable nulliparous compartments 23 
(Bach et al., 2017). Post-involution cells upregulate genes involved in immune response 24 
(Mfge8 and Tgfb3) and lactation (Csn2, Lalba, l, Lipa and Cidea). The parity effect seems 25 
confined to the luminal progenitor population (Bach et al., 2017), which may be already primed 26 
towards the alveolar fate due to continued transcription from these loci. In mammary epithelial 27 
cells, X chromosome inactivation does not appear to be random, and expression of the X-linked 28 
gene Rnf12 from the paternal allele is required for alveolar cell differentiation and milk 29 
production. Cells without Rnf12/RLIM undergo cell death upon differentiation, with the effect 30 
being more pronounced in basal than luminal cells (Jiao et al., 2012). This indicates that 31 
silencing of the maternal allele of Rnf12 is non-random or could be the result of 32 
progenitor/MaSCs that have an active paternal X chromosome have a growth advantage over 33 
those with an active maternal X chromosome. 34 
Figure Legends 35 
 36 
Fig. 1. Overview of embryonic and adult mammary gland development. (A) Mammary 37 
placodes are visible at E11.5 and give rise to the mammary buds by E12.5. Recent lineage 38 
tracing and single cell genomic studies show that a subset of fMaSCs become restricted to the 39 
basal and luminal lineages between E12.5 and E18.5. (B) Summary of the various stages of 40 
adult mammary gland development including changes induced by pregnancy. Inset is a cartoon 41 
highlighting the different cell types in a cross section of a mammary duct. Highlighted in 42 
 27 
different colours are the different progenitor and differentiated luminal and basal epithelial 1 
cells (see Fig. 2 for hierarchy of cells). It is important to note how the epithelial ductal network 2 
is surrounded by immune cells, adipocytes and fibroblasts – all of which contribute to the 3 
development and homeostasis of the mammary gland. More work is needed to fully understand 4 
the heterotypic interactions between epithelial and non-epithelial cells in the mammary gland 5 
and plasticity between different cell fates.  6 
 7 
Fig. 2. A proposed cellular hierarchy model of mammary stem and progenitor cells. 8 
Lineage tracing studies suggest that multipotent mammary epithelial stem cells are 9 
predominantly active during embryonic stages of development. By birth, although some 10 
fMaSCs remain and may become quiescent adult MaSCs, the post-partum mammary gland 11 
arises predominantly from basal enduring progenitors (BEPs) and luminal enduring 12 
progenitors (LEPs) that are unipotent are fully lineage-committed. LEPs give rise to both a 13 
hormone sensing lineage (ER+/PR+) and a hormone receptor negative lineage (ER-/PR-). We 14 
suggest that a subset of the ER-/PR- progenitor cells, most likely present at the tips of side 15 
branches, gives rise to the secretory alveolar lineage during pregnancy, that predominates in 16 
lactation. This lineage expresses Elf5 and has active pStat5. We speculate that the hormone 17 
receptor status lineage bifurcation probably occurs around puberty when the final burst of 18 
ductal elongation is triggered by estrogen. Note that the quiescent MaSC indicated here 19 
represents a collection of rare quiescent cell types that express different markers such as 20 
Bcl11b, Lgr5 and Tspn8. We have not represented cycling MaSCs expressing Procr. It remains 21 
to be seen whether the different architectural localisation of these cells represents a functional 22 
heterogeneity. Given the plasticity of mammary epithelial cells we do not suggest that the 23 
hierarchical structure depicted here is unidirectional. 24 
 25 
Fig. 3. An illustration of lactation. A single alveolus is depicted. The inner layer comprises 26 
secretory luminal cells that are predominantly hormone receptor negative and have activated 27 
pStat5, a downstream mediator of prolactin signalling. Results from 3D imaging analysis 28 
indicate that only one cell per alveolus expresses high levels of keratin8. Note the presence of 29 
binucleate cells that have undergone a second round of DNA replication but have not divided. 30 
This is essential for milk production as discussed in the text. Milk fat globules (MFGs) are 31 
enveloped by plasma membrane during secretion and caseins are secreted as micelles. The 32 
shape of myoepithelial cells is dramatically different in alveoli where they adopt a stellate 33 
structure and are thinly stretched around the luminal cells. Recent imaging studies have 34 
revealed the presence of leukocytes that are closely apposed to the myoepithelial cells and 35 
adopt their shape (Hitchcock et al., 2020). The 3D images shown are (i) immunostaining of 36 
cleared tissue with an antibody to smooth muscle actin (SMA) (cyan); (ii) a higher 37 
magnification image of an alveolus showing co-immunostaining for SMA (cyan) and a pan-38 
leukocyte marker (magenta); (iii) immunostaining of luminal cell membranes with E-cadherin 39 
(green) and nuclei (DNA in blue) showing binucleate cells; (iv) immunostaining for keratin8 40 
(K8) (yellow). Some images are taken from (Davis et al., 2016) and (Hitchcock et al., 2020). 41 
 28 
Fig. 4. The stages of involution. A Single alveolus is depicted at different stages of involution. 1 
Stat3 is activated within a few hours of involution and mediates a switch in the fate of secretory 2 
mammary alveolar cells that cease milk secretion and start to uptake secreted MFGs from the 3 
lumen. These are delivered to lysosomes and processed to fatty acids that may insert into the 4 
lysosomal membrane resulting in the leakage of cathepsins into the cytosol where they execute 5 
cell death (Sargeant et al., 2014). Stat3 also upregulates the lysosomal compartment by 6 
inducing expression of the lysosomal cathepsins B and L, while concomitantly downregulating 7 
the expression of the endogenous suicide cathepsin inhibitor Spi2A (encoded by Serpina3g) 8 
that is highly expressed during lactation. Dying cells detach from the luminal epithelial layer 9 
and are shed into the lumen where they remain intact. Nuclei condense due to the activation of 10 
caspase3 in shed cells (inset), but that cell death is not perturbed in the absence of caspase 11 
activity. The first, reversible, phase of involution lasts for around 48 hours in mouse mammary 12 
gland, thereafter switching to an irreversible phase marked by collapse of the alveoli, extensive 13 
cell death, tissue remodelling, and re-appearance of lipid-filled adipocytes. The mechanism of 14 
cell death in the second phase has not been determined, but may involve apoptosis. By 144 15 
hours, the alveoli have shrunk dramatically due to the extensive death of the luminal cells and 16 
remaining alveoli cluster close to the ductal structure. Paired 3D images below the cartoons 17 
show the structure of alveoli in detail with smooth muscle actin (SMA) immunostaining in 18 
cyan and leukocytes in magenta. Note the dramatic increase in number of leukocytes at 72 19 
hours. The key for the diagram is the same as in Figure 3 and some of the images are taken 20 
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